The following are some of the latest subjects discussed in GPP3: • The most recent ICMJE authorship conditions are explained (2013) • Authorship problems that are frequently found • Author payment and repayment are now more explicitly described. • Clarification of the words "ghost fiction" and "guest authorship." • Professional medical writers: what they do and how they help • Advice on how to exchange data acceptably. Continue Reading: https://bit.ly/2OOiUNI Reference: https://pubrica.com/services/publication-support/ Why Pubrica: When you order our services, We promise you the following – Plagiarism free | always on Time | 24*7 customer support | Written to international Standard | Unlimited Revisions support | Medical writing Expert | Publication Support | Biostatistical experts | High-quality Subject Matter Experts. Contact us : Web: https://pubrica.com/ Blog: https://pubrica.com/academy/ Email: [email protected] WhatsApp : +91 9884350006 United Kingdom: +44- 74248 10299
Use of GPP3 for ethical guidance - Pubrica
USE OF GPP3 FOR
ETHICAL
GUIDANCE
An Academic presentation by
Dr. Nancy Agnes, Head, Technical Operations, Pubrica
Group: www.pubrica.com
Email: [email protected]
Today's Discussion
Outline
In-Brief
Introduction
GPP Historical Archive
What is New in GPP3
Role of ISMPP
Future Scopes
Conclusion
In-Brief
GPP3 is a revision of the original Good Publication Practice (GPP)
standards, which were first published in 2003 and last revised in
2009. The ISMPP GPP3 Steering Committee has revised the 2009
edition of the Good Publication Practice Guidelines (GPP2) to
emphasise integrity and transparency in industry-sponsored
publication planning and development in today's environment.
Introduction
GPP3 is a revised version of the Good Publishing
Practice (GPP) guideline that offers guidelines for
persons and organisations involved in disseminating
research findings funded or assisted by
pharmaceutical, medical device, diagnostics, and
biotechnology industries.
The guidelines are meant to help individuals and
organisations adhere to legal and regulatory
standards while ensuring fair and open publishing
activities.
These guidelines apply to p
eer-reviewed journal publications and oral and
poster presentations at science conferences.
Contd...
The following are some of the latest subjects discussed in
GPP3:
The most recent ICMJE authorship conditions are explained
(2013) Authorship problems that are frequently found
Author payment and repayment are now more explicitly
described. Clarification of the words "ghost fiction" and
"guest authorship."
Professional medical writers: what they do and how
they help Advice on how to exchange data
acceptably.
GPP
GPP3 FOR ETHICAL GUIDELINES, 2015
Historical
Archive The resulting guideline adds new parts
(Principles of Good Publication Practice for
Company-Sponsored Medical Research, Data
Sharing, Studies That Should Be Published,
and Plagiarism).
It builds on authorship requirements and
widespread authorship concerns established by
the International Committee of Medical Journal
Editors., Expand details on the position of
medical writers and explain appropriate author
payment and reimbursement.
Contd...
Individuals and organisations can embody honesty, transparency, and
obligation for reliable, complete, and transparent reporting in their
publications and presentations by adopting good publishing practices
(including GPP3).
Step 1: ISMPP
Step 2: Publication Steering Committee
Step 3: Reviewer Panel
Step 4: Steering Committee
Contd...
GPP2 GUIDELINES, 2009
International Society for Medical Publication Professionals (ISMPP)
assembled a Steering Committee to produce an updated Good Publication
Practice guide, now known as "GPP2," to discuss regulatory, guidance, and
ethical changes since 2003 and to affirm the goals of the initial 2003
publication.
GPP GUIDELINES, 2003
The critical Good Publication Practice (GPP) guidelines, released in 2003,
aimed to ensure that "clinical trials funded by pharmaceutical firms are
published responsibly and ethically."
Contd...
What is
New in
GPP3 Guidance on updated ICMJE 2013 authorship criteria
Advice on everyday issues about authorship
Author payment and compensation guidance and
clarification Further definitions of what creates guest
or ghost invention
Information on the position and
benefits of licenced medical authors has been
expanded
Contd...
Advice for appropriate data sharing.
Overall simplification of language and format with a new guiding
principles section and quick reference tables addressing guidance on
authorship criteria and joint authorship issues.
We use the terms "publications" and "presentations" interchangeably in
the guideline to refer to the wide variety of formats presented in p
eer-reviewed journals (for example, original research papers, brief
reports, analyses, or letters to the editor) and "abstracts," "posters,"
and slides for oral presentations at scientific congresses.
Contd...
"Sponsors" are organisations that offer primary resources for a
study, such as funding.
Professional medical researchers, publishing designers, and publication
administrators are known as "publication practitioners," and they
work in or with businesses.
Regulatory documents, medical education services, and marketing and
promotional materials are governed or accredited by various national
or state bodies and are not protected by this guideline.
Contd...
Role
of
ISMPP was the energetic force behind the adoption
ISMPP of the
GPP3 guideline.
By supplying logistical research paper support, giving
access to the mailing list of ISMPP participants,
sending out e-mails to members and prospective
reviewers, maintaining the database of respondents,
setting up the reviewer Web site, and reviewing the
GPP3 steering committee, the sponsor was able to
assist in the formation of the GPP3 steering
committee.
Contd...
Several members of the steering committee also sit on the ISMPP Board of
Trustees.
They did, however, contribute to GPP3 as entities, not on behalf of ISMPP.
The quality of this guideline was not guided or regulated by the ISMPP
employees.
Future Scopes
We hope that GPP3 will add the valuabl
to mthaanty are e
guidelin an arsectohmosmeendatitohe alread
eWsr iters A sdsociafrtnoiosmn, American y
aCvoauminlmacbiiltlete(esuc on Publicaotf ioSncienceEthMicse,dic
EofuropeanhAssEodciitaotrios,n European Medical aWl riters
SAcsiseonccieation ICMJE, International FederaEtdioitnors
,Pharmaceuticaol f Manufacturers & Associa,tions),
ISMPP, Medical Publishing Insights and Practices,
and the World Association of Medical Editors) all
promote responsible publishing practices and
research.
Conclusion
Because of advancements in regulatory, medical,
and journal standards, our understanding of the
publishing environment has changed.
The GPP3 guideline has been amended to keep up
with the changes.
The role, reimbursements, and increased
responsibility of MWs in the process have been
identified and elaborated to a greater extent.
Contd...
Necessitates MW staying current with current trends and undergoing
specialised training from known institutions to improve understanding
and formulate a proper strategy.
It is required to produce high-quality documentation and the bridging
of the gap between research conduct and reporting.
Avail Publication support services from Pubrica.
Contact Us
UNITED KINGDOM
+44- 7424810299
INDIA
+91-9884350006
EMAIL
[email protected]
Comments